HAEM5:B-lymphoblastic leukaemia/lymphoma with hypodiploidy: Difference between revisions
| [pending revision] | [pending revision] |
| Line 260: | Line 260: | ||
|Propagation of genetically altered cells. | |Propagation of genetically altered cells. | ||
|- | |- | ||
|''IKZF1, IKZF2, IKZF3, PAX5, EBF1, VPREB1'' | |''IKZF1, IKZF2, IKZF3, PAX5, EBF1, VPREB1''<ref name=":16" /> | ||
|B-cell development | |B-cell development | ||
|Altered lymphoid development and differentiation. | |Altered lymphoid development and differentiation. | ||
|- | |- | ||
|''PAG1'' | |''PAG1<ref name=":16" />'' | ||
|BCR signaling | |BCR signaling | ||
|Altered regulatory function in proximal B cell–receptor signaling. | |Altered regulatory function in proximal B cell–receptor signaling. | ||
|- | |- | ||
|''ETV6'' | |''ETV6<ref name=":16" />'' | ||
|Hematopoiesis | |Hematopoiesis | ||
|Not fully elucidated in this entity | |Not fully elucidated in this entity | ||
|- | |- | ||
|''ARPP21'' | |''ARPP21<ref name=":16" />'' | ||
|Calmodulin signaling | |Calmodulin signaling | ||
|Not fully elucidated in this entity | |Not fully elucidated in this entity | ||
|- | |- | ||
|''SLX4IP'' | |''SLX4IP<ref name=":16" />'' | ||
|Telomere length maintenance | |Telomere length maintenance | ||
|Not fully elucidated in this entity | |Not fully elucidated in this entity | ||
|- | |- | ||
|''CUL5'' | |''CUL5<ref name=":16" />'' | ||
|Ubiquitin pathway | |Ubiquitin pathway | ||
|Not fully elucidated in this entity | |Not fully elucidated in this entity | ||
|- | |- | ||
|''FAM53B'' | |''FAM53B<ref name=":16" />'' | ||
|Wnt signaling | |Wnt signaling | ||
|Not fully elucidated in this entity | |Not fully elucidated in this entity | ||
|- | |- | ||
|''PDS5B'' | |''PDS5B<ref name=":16" />'' | ||
|Cohesis complex | |Cohesis complex | ||
|Not fully elucidated in this entity | |Not fully elucidated in this entity | ||
|- | |- | ||
|''ANKRD11, DMD'' | |''ANKRD11, DMD<ref name=":16" />'' | ||
|Cell adhesion | |Cell adhesion | ||
|Not fully elucidated in this entity | |Not fully elucidated in this entity | ||